261 related articles for article (PubMed ID: 36060450)
21. Current opinion in urology 2017: focal therapy of small renal lesions.
Johnson BA; Cadeddu JA
Curr Opin Urol; 2018 Mar; 28(2):166-171. PubMed ID: 29303914
[TBL] [Abstract][Full Text] [Related]
22. Percutaneous image-guided cryoablation of small renal masses.
Patel N; King AJ; Breen DJ
Abdom Radiol (NY); 2016 Apr; 41(4):754-66. PubMed ID: 26915090
[TBL] [Abstract][Full Text] [Related]
23. [Focal therapy for small renal masses : Observation, ablation or surgery].
Wendler JJ; Friebe B; Baumunk D; Blana A; Franiel T; Ganzer R; Hadaschik B; Henkel T; Köhrmann KU; Köllermann J; Kuru T; Machtens S; Roosen A; Salomon G; Schlemmer HP; Sentker L; Witzsch U; Liehr UB; Ricke J; Schostak M
Urologe A; 2016 May; 55(5):594-606. PubMed ID: 27119957
[TBL] [Abstract][Full Text] [Related]
24. Decision Making: Thermal Ablation Options for Small Renal Masses.
McCarthy CJ; Gervais DA
Semin Intervent Radiol; 2017 Jun; 34(2):167-175. PubMed ID: 28579684
[TBL] [Abstract][Full Text] [Related]
25. [Ablative therapy of small renal masses].
Kriegmair MC; Wagener N; Diehl SJ; Rathmann N
Urologe A; 2018 Mar; 57(3):285-294. PubMed ID: 29396626
[TBL] [Abstract][Full Text] [Related]
26. State of the ablation nation: a review of ablative therapies for cure in the treatment of hepatocellular carcinoma.
Salati U; Barry A; Chou FY; Ma R; Liu DM
Future Oncol; 2017 Jul; 13(16):1437-1448. PubMed ID: 28685607
[TBL] [Abstract][Full Text] [Related]
27. Percutaneous Microwave Ablation versus Laparoscopic Partial Nephrectomy for cT1a Renal Cell Carcinoma: A Propensity-matched Cohort Study of 1955 Patients.
Yu J; Zhang X; Liu H; Zhang R; Yu X; Cheng Z; Han Z; Liu F; Hao G; Mu MJ; Liang P
Radiology; 2020 Mar; 294(3):698-706. PubMed ID: 31961239
[TBL] [Abstract][Full Text] [Related]
28. Irreversible Electroporation for the Treatment of Small Renal Masses: 5-Year Outcomes.
Dai JC; Morgan TN; Steinberg RL; Johnson BA; Garbens A; Cadeddu JA
J Endourol; 2021 Nov; 35(11):1586-1592. PubMed ID: 33926224
[No Abstract] [Full Text] [Related]
29. Image-guided minimally invasive treatment for small renal cell carcinoma.
Krokidis ME; Kitrou P; Spiliopoulos S; Karnabatidis D; Katsanos K
Insights Imaging; 2018 Jun; 9(3):385-390. PubMed ID: 29626285
[TBL] [Abstract][Full Text] [Related]
30. Update on thermal ablation of renal cell carcinoma: oncologic control, technique comparison, renal function preservation, and new modalities.
Zagoria RJ; Childs DD
Curr Urol Rep; 2012 Feb; 13(1):63-9. PubMed ID: 22076695
[TBL] [Abstract][Full Text] [Related]
31. Percutaneous Ablation Versus Robotic Partial Nephrectomy in the Treatment of cT1b Renal Tumors: Oncologic and Functional Outcomes of a Propensity Score-weighted Analysis.
Rembeyo G; Correas JM; Jantzen R; Audenet F; Dariane C; Delavaud C; Mejean A; Timsit MO
Clin Genitourin Cancer; 2020 Apr; 18(2):138-147. PubMed ID: 31982346
[TBL] [Abstract][Full Text] [Related]
32. Contemporary Status of Percutaneous Ablation for the Small Renal Mass.
Shin BJ; Chick JF; Stavropoulos SW
Curr Urol Rep; 2016 Mar; 17(3):23. PubMed ID: 26874535
[TBL] [Abstract][Full Text] [Related]
33. Radiofrequency Ablation, Cryoablation, and Microwave Ablation for the Treatment of Small Renal Masses: Efficacy and Complications.
Bertolotti L; Bazzocchi MV; Iemma E; Pagnini F; Ziglioli F; Maestroni U; Patera A; Natale MP; Martini C; De Filippo M
Diagnostics (Basel); 2023 Jan; 13(3):. PubMed ID: 36766493
[TBL] [Abstract][Full Text] [Related]
34. The Role of Ablation and Minimally Invasive Techniques in the Management of Small Renal Masses.
Salagierski M; Wojciechowska A; Zając K; Klatte T; Thompson RH; Cadeddu JA; Kaouk J; Autorino R; Ahrar K; Capitanio U;
Eur Urol Oncol; 2018 Oct; 1(5):395-402. PubMed ID: 31158078
[TBL] [Abstract][Full Text] [Related]
35. Ablative Therapy for Small Renal Masses.
Taylor BL; Stavropoulos SW; Guzzo TJ
Urol Clin North Am; 2017 May; 44(2):223-231. PubMed ID: 28411914
[TBL] [Abstract][Full Text] [Related]
36. Radiofrequency Ablation, Cryoablation, and Microwave Ablation for T1a Renal Cell Carcinoma: A Comparative Evaluation of Therapeutic and Renal Function Outcomes.
Zhou W; Herwald SE; McCarthy C; Uppot RN; Arellano RS
J Vasc Interv Radiol; 2019 Jul; 30(7):1035-1042. PubMed ID: 30956075
[TBL] [Abstract][Full Text] [Related]
37. Percutaneous ablation techniques for renal cell carcinoma: current status and future trends.
Filippiadis D; Mauri G; Marra P; Charalampopoulos G; Gennaro N; De Cobelli F
Int J Hyperthermia; 2019 Oct; 36(2):21-30. PubMed ID: 31537160
[TBL] [Abstract][Full Text] [Related]
38. New technologies in tumor ablation.
Singla N; Gahan J
Curr Opin Urol; 2016 May; 26(3):248-53. PubMed ID: 26967263
[TBL] [Abstract][Full Text] [Related]
39. [What can/should be treated in kidney tumors and when].
Sommer CM; Vollherbst DF; Richter GM; Kauczor HU; Pereira PL
Radiologe; 2017 Feb; 57(2):80-89. PubMed ID: 28130580
[TBL] [Abstract][Full Text] [Related]
40. Thermal Ablation of T1c Renal Cell Carcinoma: A Comparative Assessment of Technical Performance, Procedural Outcome, and Safety of Microwave Ablation, Radiofrequency Ablation, and Cryoablation.
Zhou W; Arellano RS
J Vasc Interv Radiol; 2018 Jul; 29(7):943-951. PubMed ID: 29628298
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
